Abstract:Background: Endothelial cells (ECs) use glycolysis to produce energy. In preclinical models of peripheral arterial disease, further activation of EC glycolysis was ineffective or deleterious in promoting hypoxia-dependent angiogenesis, whereas pentose phosphate pathway activation was effective. Hexosamine biosynthesis pathway, pentose phosphate pathway, and glycolysis are closely linked. Glucosamine directly activates hexosamine biosynthesis pathway. Methods: Hind-limb ischemia in endothelial nitric oxide synthase knockout (eNOS-/-) and BALB/c mice was used. Glucosamine (600 μg/g per day) was injected intraperitoneally. Blood flow recovery was assessed using laser Doppler perfusion imaging and angiogenesis was studied by CD31 immunostaining. In vitro, human umbilical vein ECs and mouse microvascular ECs with glucosamine, L-glucose, or vascular endothelial growth factor (VEGF165a) were tested under hypoxia and serum starvation. Cell Counting Kit-8, tube formation, intracellular reactive oxygen species, electric cell-substrate impedance sensing, and fluorescein isothiocyanate dextran permeability were assessed. Glycolysis and oxidative phosphorylation were assessed by seahorse assay. Gene expression was assessed using RNA sequencing, real-time quantitative polymerase chain reaction, and Western blot. Human muscle biopsies from patients with peripheral arterial disease were assessed for EC O-GlcNAcylation before and after supervised exercise versus standard medical care. Results: On day 3 after hind-limb ischemia, glucosamine-treated versus control eNOS-/- mice had less necrosis (n=4 or 5 per group). Beginning on day 7 after hind-limb ischemia, glucosamine-treated versus control BALB/c mice had higher blood flow, which persisted to day 21, when ischemic muscles showed greater CD31 staining per muscle fiber (n=8 per group). In vitro, glucosamine versus L-glucose ECs showed improved survival (n=6 per group) and tube formation (n=6 per group). RNA sequencing of glucosamine versus L-glucose ECs showed increased amino acid metabolism (n=3 per group). That resulted in increased oxidative phosphorylation (n=8-12 per group) and serine biosynthesis pathway without an increase in glycolysis or pentose phosphate pathway genes (n=6 per group). This was associated with better barrier function (n=6-8 per group) and less reactive oxygen species (n=7 or 8 per group) compared with activating glycolysis by VEGF165a. These effects were mediated by activating transcription factor 4, a driver of exercise-induced angiogenesis. In muscle biopsies from humans with peripheral arterial disease, EC/O-GlcNAcylation was increased by 12 weeks of supervised exercise versus standard medical care (n=6 per group). Conclusion: In cells, mice, and humans, activation of hexosamine biosynthesis pathway by glucosamine in peripheral arterial disease induces an "exercise-like" angiogenesis and offers a promising novel therapeutic pathway to treat this challenging disorder.

P38 Mitogen-activated Protein Kinase is Required for Glucosamine-Induced Endothelial Nitric Oxide Synthase Uncoupling and Plasminogen-Activator Inhibitor Expression.

A Novel Angiogenesis Role of GLP-1(32-36) to Rescue Diabetic Ischemic Lower Limbs Via GLP-1R-Dependent Glycolysis

Relationship Between High Glucose-Induced Hepatic Stellate Cell Activation and the P38mapk Signaling Pathway

Effects of High Glucose on the Activity of GSH-PX,the Expressions of NOS and ICAM-1 in Human Umbilical Vein Endothelial Cells

Glucosamine-Mediated Hexosamine Biosynthesis Pathway Activation Uses ATF4 to Promote "Exercise-Like" Angiogenesis and Perfusion Recovery in PAD

P38 Mitogen-Activated Protein Kinase is Involved in Arginase-Ii-mediated Enos-Uncoupling in Obesity.

The CREB/KMT5A complex regulates PTP1B to modulate high glucose-induced endothelial inflammatory factor levels in diabetic nephropathy

Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice

Lysophosphatidylcholine Up-Regulates Human Endothelial Nitric Oxide Synthase Gene Transactivity By C-Jun N-Terminal Kinase Signalling Pathway

P38mapk and ERK Promote Nitric Oxide Production in Cultured Human Retinal Pigmented Epithelial Cells Induced by High Concentration Glucose.

Endothelial Nitric Oxide Synthase-Dependent Tyrosine Nitration Of Prostacyclin Synthase In Diabetes In Vivo

High Glucose Level Stimulates P38 Mitogen - Actived Protein Kinase Expression in Human Umibilical Vein Endothelial Cell

[Involvement of P38 MAPK Pathway in GLP-1-induced Inhibition of Apoptosis in Human Umbilical Vein Endothelial Cells].

p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.

Glucosamine Induces Increased Musclin Gene Expression Through Endoplasmic Reticulum Stress-Induced Unfolding Protein Response Signaling Pathways in Mouse Skeletal Muscle Cells.

P38α Subtype is a Potential Target to Inhibit Enos Activity and NO Production in Human Endothelial Cells

Downregulation of Human Endothelial Nitric Oxide Synthase Promoter Activity by P38 Mitogen-Activated Protein Kinase Activation

Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity

Glucosamine increases macrophage lipid accumulation by regulating the mammalian target of rapamycin signaling pathway

Emodin Ameliorates High-Glucose Induced Mesangial P38 Over-Activation and Hypocontractility Via Activation of PPARγ

Hepatic p38α regulates gluconeogenesis by suppressing AMPK.